Komori
Tomita Electric (6898) · FactIncrease in R&D Expenses for the Interim Period

Expenditure on research and development activities

First written in FY2018-Q2. . Latest entry: FY2027-H1.

30entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q2 – FY2027-H12017: 22018: 420182019: 320192020: 420202021: 420212022: 420222023: 320232024: 320242025: 120252026: 22026
Same theme, other companies
Decrease in R&D expensesA theme 50 companies write about · 46 as a headwind · 4 as a tailwind

42 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Increase in R&D Expenses for the Interim PeriodAnnual report

    「The Group's total research and development expenditure for the current interim consolidated accounting period was ¥22 million.」

    Research and development expenditure was ¥22 million, up from ¥20 million in the same period of the previous fiscal year. The company also stated that there had been no material changes in its research and development activities.
  2. FY2026Decline in R&D ExpensesAnnual report

    「Research and development expenditure incurred during the current fiscal year was ¥42 million.」

    Research and development expenditure for the current fiscal year was ¥42.020 million, down from ¥46.369 million in the previous fiscal year.
  3. FY2026-H1Decrease in interim R&D expenseAnnual report

    「The Group's total research and development expenditure for the current interim consolidated accounting period was ¥20 million.」

    Research and development expenditure for the current interim consolidated accounting period was ¥20 million, down from ¥23 million in the same period of the previous fiscal year. The company stated that there had been no material changes in its research and development activities.
  4. FY2025-H1Interim research and development expenditure: ¥20 millionAnnual report

    「The Group's total research and development expenditure for the current interim consolidated accounting period was ¥20 million.」

    Research and development expenditure for the current interim consolidated accounting period was ¥20 million, down from ¥23 million in the same period of the previous fiscal year.
  5. FY2025-Q1Research and development expenses: ¥11 millionAnnual report

    「The Group's total research and development expenditure for the current first-quarter consolidated cumulative period was ¥11 million.」

    Research and development expenditure for the current first-quarter consolidated cumulative period was ¥11 million, unchanged from the same period of the previous fiscal year.
  6. FY2024Research and development expenditure: ¥44 millionAnnual report

    「Research and development expenditure incurred during the current fiscal year was ¥44 million.」

    Research and development expenditure for the current fiscal year was ¥44.101 million, down from ¥51.192 million in the previous fiscal year.
  7. FY2024-Q3Research and development expenditure: ¥34 millionAnnual report

    「The Group's total research and development expenditure for the current third-quarter consolidated cumulative period was ¥34 million.」

    Research and development expenditure for the third-quarter consolidated cumulative period was ¥34 million, down from ¥37 million in the same period of the previous fiscal year. The company stated that there had been no material changes in its research and development activities.
  8. FY2024-Q2Research and development expenditure: ¥21 millionAnnual report

    「The Group's total research and development expenditure for the current second-quarter consolidated cumulative period was ¥21 million.」

    Research and development expenditure for the current second-quarter consolidated cumulative period was ¥21 million, down from ¥23 million in the same period of the previous fiscal year.
  9. FY2023Research and development expenditure: ¥51 millionAnnual report

    「Research and development expenditure incurred during the current fiscal year was ¥51 million.」

    Research and development expenditure for the current fiscal year was ¥51.192 million, up from ¥43.306 million in the previous fiscal year.
  10. FY2023-Q3Research and development expenses: ¥37 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥37 million.」

    Research and development expenditure for the current third-quarter consolidated cumulative period was ¥37 million, up from ¥30 million in the same period of the previous fiscal year.
  11. FY2023-Q2Research and development expenditure: ¥23 millionAnnual report

    「The Group's total research and development expenditure for the current second-quarter consolidated cumulative period was ¥23 million.」

    The company disclosed research and development expenditure of ¥23 million for the current second-quarter consolidated cumulative period, up from ¥20 million in the same period of the previous fiscal year.
  12. FY2023-Q1Research and development expenses: ¥11 millionAnnual report

    「The Group's total research and development expenditure for the current first-quarter consolidated cumulative period was ¥11 million.」

    The company disclosed research and development expenditure of ¥11 million for the current first-quarter consolidated cumulative period.
  13. FY2022Research and development expenditure: ¥43 millionAnnual report

    「Research and development expenditure incurred during the current fiscal year was ¥43 million.」

    Research and development expenditure for the current fiscal year was ¥43 million (¥43.306 million as disclosed in the notes), up from ¥40.678 million in the previous fiscal year.
  14. FY2022-Q3Research and development expenses: ¥30 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥30 million.」

    The company disclosed research and development expenditure of ¥30 million for the third-quarter consolidated cumulative period, up from ¥20 million in the second-quarter cumulative period.
  15. FY2022-Q2Research and development expenditure: ¥20 millionAnnual report

    「The Group's total research and development expenditure for the current second-quarter consolidated cumulative period was ¥20 million.」

    The company disclosed research and development expenditure of ¥20 million for the current second-quarter consolidated cumulative period.
  16. FY2022-Q1Research and development expenditure: ¥10 millionAnnual report

    「The Group's total research and development expenditure for the current first-quarter consolidated cumulative period was ¥10 million.」

    The company disclosed research and development expenditure of ¥10 million for the current first-quarter consolidated cumulative period.
  17. FY2021Research and development expenditure: ¥40.7 millionAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥40 million.」

    Research and development expenditure for the current fiscal year was ¥40 million, or ¥40.678 million as disclosed in the notes, up from ¥40.222 million in the previous fiscal year.
  18. FY2021-Q3Research and development expenditure: ¥31 millionAnnual report

    「The Group's total research and development expenditure for the current third-quarter consolidated cumulative period was ¥31 million.」

    The company disclosed research and development expenditure of ¥31 million for the current third-quarter consolidated cumulative period, up from ¥20 million in the second-quarter cumulative period.
  19. FY2021-Q2Research and development expenditure: ¥20 millionAnnual report

    「The Group's total research and development expenditure for the current second-quarter consolidated cumulative period was ¥20 million.」

    The company disclosed research and development expenditure of ¥20 million for the current second-quarter consolidated cumulative period.
  20. FY2021-Q1Research and development expenses: ¥11 millionAnnual report

    「The Group's total research and development expenditure for the current first-quarter consolidated cumulative period was ¥11 million.」

    The company disclosed research and development expenditure of ¥11 million for the current first-quarter consolidated cumulative period.
  21. FY2020Research and development expenses: ¥40 millionAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥40 million.」

    Research and development expenses for the consolidated fiscal year were disclosed as ¥40 million (¥40.222 million in the notes).
  22. FY2020-Q3Research and development expenses: ¥37 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥37 million.」

    The company disclosed research and development activities of ¥37 million for the cumulative third quarter of the current consolidated fiscal year, up from ¥25 million for the previous cumulative quarter.
  23. FY2020-Q2Research and development expenses: ¥25 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥25 million.」

    The company disclosed research and development activities of ¥25 million for the cumulative second quarter of the current consolidated fiscal year.
  24. FY2020-Q1Research and development expenses: ¥13 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥13 million.」

    The company disclosed research and development activities of ¥13 million for the cumulative first quarter of the current consolidated fiscal year.
  25. FY2019-Q3Research and development expenses: ¥30 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥30 million.」

    The company disclosed research and development activities of ¥30 million for the cumulative third quarter of the consolidated fiscal year, up from ¥19 million for the cumulative second quarter.
  26. FY2019-Q2Research and development expenses: ¥19 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥19 million.」

    The company disclosed research and development activities of ¥19 million for the cumulative second quarter of the consolidated fiscal year.
  27. FY2019-Q1Research and development expenses: ¥9 millionAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥9 million.」

    The company disclosed research and development activities of ¥9 million for the cumulative first quarter of the current consolidated fiscal year.
  28. FY2018Research and development expenses: ¥37.6 millionAnnual report

    「Research and development expenses incurred during the consolidated fiscal year were ¥37 million.」

    Research and development expenses for the consolidated fiscal year were ¥37.584 million, down from ¥41.890 million in the previous fiscal year.
  29. FY2018-Q3Increase in R&D ExpensesAnnual report

    「The amount of research and development activities for the group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥27 million.」

    The company disclosed research and development activities of ¥27 million for the cumulative third quarter of the consolidated fiscal year, up from ¥18 million for the cumulative second quarter.
  30. FY2018-Q2First statedAnnual report

    「The Group's total research and development expenditure for the cumulative second quarter of the fiscal year was ¥18 million.」

    The company disclosed research and development activities of ¥18 million for the cumulative second quarter of the consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tomita Electric yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expenditure on research and development activities | TOMITA ELECTRIC CO.,LTD. (6898) | Komori